Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Novavax reported $199.05M in Debt for its fiscal quarter ending in March of 2023.

Debt Change
Adma Biologics ADMA:US USD 144.3M 1.47M
Agenus AGEN:US USD 13.65M 490K
AstraZeneca AZN:LN USD 31.5B 2.27B
BioCryst Pharmaceuticals BCRX:US USD 746.93M 13.65M
Dynavax Technologies DVAX:US USD 221.86M 277K
Geron GERN:US USD 51.4M 242K
GlaxoSmithKline GSK:LN GBP 20.9B 82M
MannKind MNKD:US USD 378.03M 461K
Moderna Inc MRNA:US USD 984M 89M
Novartis NVS:US USD 29.15B 1.24B
Novavax NVAX:US USD 199.05M 350.73M
Peregrine Pharmaceuticals PPHM:US USD 142.58M 136K
Sarepta Therapeutics SRPT:US USD 1.23B 310.01M
TG Therapeutics TGTX:US USD 96.5M 25.37M